dpp4 glp 1 combination Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)
Description
Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat
RESULTS: Following the breakfast, GLP-1 infusion suppressed ratings of hunger and prospective food consumption (P<0.05), whereas all other subjective ratings and ad libitum energy intake were unaffected
Wegovy, however, is the first weekly injectable treatment in South Africa that is specifically registered and approved for weight management.
There are two types of RLS: secondary and primary
Honest answers, not panic.
